Fuji Pharma Co., Ltd. TOP > Investor Relations > Corporate Profile
Development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products.
| Clients | People seeking good health, those involved in medical services and pharmaceuticals |
|---|---|
| Products and Services | Medical care for women, in vitro diagnostics, acute medical care products and curative medicine (injection agents), and information regarding pharmaceuticals and health |
| Core Competency | Research and development, manufacture, and marketing in selected disease domains Passionate about quality of products, people, and management Hard- working employees and partners |
Head Office |
5-7 Sanban-cho, Chiyoda-ku, Tokyo 102-0075, Japan TEL: +81(0)3-3556-3344 ; Fax: +81(0)3556-4455 |
|---|---|
| Established | April 1965 |
| Capital | ￥2,447 million |
| Stock Listings | Tokyo Stock Exchange, Second Section |
| Fiscal Year-End | September |
| Representative Director | Hirofumi Imai, President and Chief Executive Officer |
| Board Members | Satoru Hiromi, Managing Director Kenichi Tokunaga, Managing Director Toyoyuki Kamide, Director Atsuya Mitsuhashi, Director Tadahiro Kozawa, Outside Director Masayuki Uchida, Outside Director Minoru Nakamura, Full-time Outside Corporate Auditor Fujiaki Mimura, Outside Corporate Auditor Akira Sato, Outside Corporate Auditor |
| Office Locations | Head Office: Tokyo Branch Offices: Tokyo, Nagoya, Osaka, Fukuoka Sales Offices: Sapporo, Sendai, Toyama Plant: Toyama |
| Number of Employees | 501, average age: 38 (As of September 2010) |
